DJIA 17,010.59 -32.31 -0.19%
NASDAQ 4,475.03 -18.36 -0.41%
S&P 500 1,963.53 -8.76 -0.44%
market minute promo

Epizyme (NASDAQ: EPZM)

26.51 -0.60 (-2.21%)

Quote as of


company name or ticker

Recent Quotes

EPZM $26.51 -2.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.06
Previous Close $27.11
Daily Range $26.49 - $27.06
52-Week Range $18.10 - $42.71
Market Cap $890.3M
P/E Ratio 27.95
Dividend (Yield) $0.00 (0.0%)
Volume 7,539
Average Daily Volume 369,766
Current FY EPS -$1.68

Sector

Industry

Epizyme (EPZM) Description

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. Website: http://www.epizyme.com/

News & Commentary Rss Feed

Why Epizyme Inc. Shares Rocketed Higher

Epizyme shares soar after the company reaches another creative milestone with partner GlaxoSmithKline.

Epizyme (EPZM) Downgraded From Hold to Sell

UPDATE: Mizuho Securities USA Initiates Coverage On Epizyme Inc On Epigenetics Pure Play

Benzinga's Top Initiations

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Epizyme, Inc. Announces Resignation Of President And CFO Jason Rhodes

Epizyme Announces Resignation Of President And CFO Jason Rhodes

InsiderInsights.com Daily Round Up 8/28/14: Republic Services, OPKO Health, Saba Software And OFS Ca

InsiderInsights.com Daily Round Up 8/28/14: Republic Services, OPKO Health, Saba Software And OFS Capital

Monday Sector Leaders: Biotechnology, Drugs

Epizyme: Strong Early Data But Reserving Judgment Until Final Results

Zacks' Bull Of The Day: Epizyme

See More EPZM News...